Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: A comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data

被引:6
|
作者
Liu, Zheyu [1 ,2 ]
Zhang, Yefei [1 ,2 ]
Franzin, Luisa [3 ]
Cormier, Janice N. [4 ]
Chan, Wenyaw [2 ]
Xu, Hua [5 ]
Du, Xianglin L. [1 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, Dept Biostat, Sch Publ Hlth, Houston, TX 77030 USA
[3] Univ Texas Hlth Sci Ctr Houston, Dept Management Policy & Community Hlth, Sch Publ Hlth, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Univ Texas Sch Biomed Informat, Houston, TX USA
关键词
breast cancer; colorectal cancer; incidence rates; trends; relative risks; CIGARETTE-SMOKING; STATISTICS;
D O I
10.3892/ijo.2015.2881
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Few studies have examined the cancer incidence trends in the state of Texas, and no study has ever been conducted to compare the temporal trends of breast and colorectal cancer incidence in Texas with those of the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) in the United States. This study aimed to conduct a parallel comparison between the Texas Cancer Registry and the National Cancer Institute's SEER on cancer incidence from 1995 to 2011. A total of 951,899 breast and colorectal cancer patients were included. Age-adjusted breast cancer incidence was 134.74 per 100,000 in Texas and 131.78 per 100,000 in SEER in 1995-2011, whereas age-adjusted colorectal cancer incidence was 50.52 per 100,000 in Texas and 49.44 per 100,000 in SEER. Breast cancer incidence increased from 1995 to 2001, decreased from 2002 to 2006, and then remained relatively stable from 2007 to 2011. For colorectal cancer, the incidence increased in 1995-1997, and then decreased continuously from 1998 to 2011 in Texas and SEER areas. Incidence rates and relative risks by age, gender and ethnicity were identical between Texas and SEER.
引用
收藏
页码:1819 / 1826
页数:8
相关论文
共 50 条
  • [21] Incidence and trends of hepatic cancer among children and adolescents in the United States from 2000 to 2017: Evidence from the Surveillance, Epidemiology, and End Results registry data
    Peiyi Li
    Yujia Kong
    Jing Guo
    Xu Ji
    Xuesong Han
    Bo Zhang
    Cancer Causes & Control, 2023, 34 (1) : 69 - 79
  • [22] Incidence and trends of hepatic cancer among children and adolescents in the United States from 2000 to 2017: Evidence from the Surveillance, Epidemiology, and End Results registry data
    Li, Peiyi
    Kong, Yujia
    Guo, Jing
    Ji, Xu
    Han, Xuesong
    Zhang, Bo
    CANCER CAUSES & CONTROL, 2023, 34 (01) : 69 - 79
  • [23] Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis
    Liu, Ning
    Johnson, Kimberly J.
    Ma, Cynthia X.
    CLINICAL BREAST CANCER, 2018, 18 (05) : E997 - E1002
  • [24] A Surveillance, Epidemiology, and End Results Registry Analysis of Prostate Cancer Modality Time Trends by Age
    Terakedis, Breanne E.
    Rossi, Peter J.
    Liauw, Stanley L.
    Johnstone, Peter A. S.
    Jani, Ashesh B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 619 - 623
  • [25] Projecting prostate cancer incidence & mortality trends using the Surveillance, Epidemiology and End Results (SEER) data.
    Sarma, AV
    Schottenfeld, D
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) : s15 - s15
  • [26] Trends in Breast Cancer Incidence and Mortality in the United States From 2004-2018: A Surveillance, Epidemiology, and End Results (SEER)-Based Study
    Bazzi, Talal
    Al-Husseini, Muneer
    Saravolatz, Louis
    Kafri, Zyad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [27] Cancer survival and incidence from the surveillance, epidemiology, and end results (SEER) program
    Ries, LAG
    Reichman, ME
    Lewis, DR
    Hankey, BF
    Edwards, BK
    ONCOLOGIST, 2003, 8 (06): : 541 - 552
  • [28] Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992-2013
    Noone, Anne-Michelle
    Cronin, Kathleen A.
    Altekruse, Sean F.
    Howlader, Nadia
    Lewis, Denise R.
    Petkov, Valentina I.
    Penberthy, Lynne
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (04) : 632 - 641
  • [29] Feasibility Study for Collection of HER2 Data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program Central Cancer Registries
    Reichman, Marsha E.
    Altekruse, Sean
    Li, Christopher I.
    Chen, Vivien W.
    Deapen, Dennis
    Potts, Mary
    Wu, Xiao-Cheng
    Morrell, Donna
    Hafterson, Jennifer
    Phipps, Amanda I.
    Harlan, Linda C.
    Ries, Lynn G.
    Edwards, Brenda K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (01) : 144 - 147
  • [30] Comparing national cancer registries: The National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program
    Mohanty, Sanjay
    Bilimoria, Karl Y.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (07) : 629 - 630